Finance

Lists
BDTX:NASDAQ
Black Diamond Therapeutics Inc
US$1,72
+1,48%
(+0,025) 1D
3 ສ.ຫ., 11 ໂມງ 8 ນາທີ 16 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDTX...
Open
US$1,73
High
US$1,73
Low
US$1,68
Mkt. cap
໙໘,໒໗ ລ້ານ
Avg. vol.
໑,໕໓ ລ້ານ
Volume
໑໑໙,໐໙ ພັນ
52-wk high
US$4,94
52-wk low
US$1,60
EPS
US$-0,76
Beta
໓,໒໕
Shares outstanding
໕໗,໓໐ ລ້ານ
No. of employees
໒໑
Open
US$1,73
High
US$1,73
Low
US$1,68
Mkt. cap
໙໘,໒໗ ລ້ານ
Avg. vol.
໑,໕໓ ລ້ານ
Volume
໑໑໙,໐໙ ພັນ
52-wk high
US$4,94
52-wk low
US$1,60
EPS
US$-0,76
Beta
໓,໒໕
Shares outstanding
໕໗,໓໐ ລ້ານ
No. of employees
໒໑
News stories
From sources across the web
About Black Diamond Therapeutics Inc
CEO-
Employees21
Founded2014
Headquarters-
SectorBiotechnology
Websiteblackdiamondtherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to BDTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BDTX in the last 3 months.
Highest
Current US$1,72
US$14,00 (+716,33%)
Average
US$11,00 (+541,40%)
Lowest
US$8,00 (+366,47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Maintained
US$14,00
+716,3%
06/01/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
US$8,00
+366,5%
05/22/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$11,00
+541,4%
05/22/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/07/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
US$8,00
+366,5%
03/17/2026
Next call ໃນອີກ 10 ມື້
ພະຫັດ 13 ສ.ຫ., 15:30
Fiscal period
Q2 2026
EPS / Est. (USD)
- / US$-0,20
Revenue / Est. (USD)
- / ໐,໐໐
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,32 ລ້ານ
7,44 ລ້ານ
6,30 ລ້ານ
7,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,10 ລ້ານ
3,54 ລ້ານ
3,97 ລ້ານ
4,26 ລ້ານ
Operating expense
13,42 ລ້ານ
10,98 ລ້ານ
10,26 ລ້ານ
11,26 ລ້ານ
Total operating expenses
13,42 ລ້ານ
10,98 ລ້ານ
10,26 ລ້ານ
11,26 ລ້ານ
Operating income
-13,42 ລ້ານ
-10,98 ລ້ານ
-10,26 ລ້ານ
-11,26 ລ້ານ
Other non operating income
1,74 ລ້ານ
1,32 ລ້ານ
1,16 ລ້ານ
1,20 ລ້ານ
EBT including unusual items
-10,56 ລ້ານ
-8,50 ລ້ານ
-15,12 ລ້ານ
-9,04 ລ້ານ
EBT excluding unusual items
-10,56 ລ້ານ
-8,50 ລ້ານ
-7,92 ລ້ານ
-9,04 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10,56 ລ້ານ
-8,50 ລ້ານ
-15,12 ລ້ານ
-9,04 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,19
-0,15
-0,14
-0,16
Interest and investment income
1,12 ລ້ານ
1,16 ລ້ານ
1,18 ລ້ານ
1,02 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
1,12 ລ້ານ
1,16 ລ້ານ
1,18 ລ້ານ
1,02 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,33 ລ້ານ
-10,89 ລ້ານ
-10,20 ລ້ານ
-11,23 ລ້ານ
Gain or loss from assets sale
-10,00 ພັນ
-1,00 ພັນ
-3,00 ພັນ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google